Skip to content

13F-HR filed by Slate Path Capital LP

Slate Path Capital LP filed this 13F-HR for the quarter ended 2019-09-30, filed 2019-11-14, with 29 holding rows worth $1,510,312,000.

Accession
0001172661-19-002260
Filed
2019-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2019

A holdings report, 29 entries on the cover page, a total value of $1,510,312,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,510,312,000 with VALUE read as thousands by filing date, 13F file number 028-15300. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SNAP INC83304A106CL A14,440,000$228,152,000thousands by filing date
CHARTER COMMUNICATIONS INC N16119P108COM469,000$193,284,000thousands by filing date
MEDICINES CO584688105COM3,695,000$184,750,000thousands by filing date
BARRICK GOLD CORP067901108COM9,795,000$169,747,000thousands by filing date
NEW YORK TIMES CO MTN BE CL A650111107Stock5,085,000$144,821,000thousands by filing date
KIRBY CORP497266106COM1,365,000$112,148,000thousands by filing date
GENERAL ELEC CO369604103COM10,350,000$92,529,000thousands by filing date
ZILLOW GROUP INC CL C CAP STK98954M200Stock2,925,000$87,224,000thousands by filing date
MOSAIC CO COM61945C103Stock4,230,000$86,715,000thousands by filing date
PAN AMERN SILVER CORP697900108COM3,600,000$56,448,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock615,000$49,458,000thousands by filing date
INTELSAT S AL5140P101COM1,100,000$25,080,000thousands by filing date
ISHARES TR464287234MSCI EMG MKT ETF333,000$13,610,000thousands by filing datecall
SIBANYE GOLD LTD825724206SPONSORED ADR2,496,253$13,480,000thousands by filing date
CYCLERION THERAPEUTICS INC23255M105COM880,000$10,666,000thousands by filing date
REATA PHARMACEUTICALS INC75615P103CL A120,000$9,635,000thousands by filing date
CUE BIOPHARMA INC22978P106COM890,000$7,503,000thousands by filing date
ZILLOW GROUP INC CLASS A98954M101CL A185,000$5,466,000thousands by filing date
INVESCO QQQ TR46090E103COM21,000$3,965,000thousands by filing datecall
BLUE APRON HLDGS INC09523Q200COM320,000$2,698,000thousands by filing date
LEXINFINTECH HLDGS LTD ADR528877103ADR225,000$2,257,000thousands by filing date
PDD HOLDINGS INC SPONSORED ADS722304102ADR65,000$2,094,000thousands by filing date
FREEPORT MCMORAN INC CL B35671D857Stock185,000$1,770,000thousands by filing date
SNAP INC83304A106CL A110,000$1,738,000thousands by filing datecall
TIDEWATER INC NEW COM88642R109Stock110,000$1,662,000thousands by filing date
FIRST MAJESTIC SILVER CORP32076V103COM170,000$1,545,000thousands by filing date
SEADRILL LTDG7998G106COM390,000$819,000thousands by filing date
MCDERMOTT INTL INC COM580037703Stock290,000$586,000thousands by filing date
UNITED STATES STL CORP NEW912909108COM40,000$462,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001172661-19-002260this filing2019-11-14acceptance time not in the bulk data set